The reproducibility of urinary phthalate metabolite concentrations has not been well characterized in non-pregnant women of reproductive age. Our primary study objectives were to describe the distribution of urinary phthalate metabolites concentrations among a population of Hmong women of reproductive age, and to evaluate intra-and inter-individual variability of phthalate metabolite concentrations. Ten phthalate metabolites were measured in first-morning urine samples collected from 45 women and 20 of their spouses, who were members of the Fox River Environment and Diet Study cohort in Green Bay, Wisconsin. Repeated first-morning urine samples were collected and analyzed from 25 women, who provided up to three samples over B1 month. Measurement variability was assessed using intraclass correlations (ICCs) and surrogate category analysis. Linear mixed models were used to evaluate the associations between participant characteristics and phthalate metabolite concentrations. Nine of the 10 phthalate metabolites were detected in 480% of all analyzed samples, of which seven were detected in all samples. As a measure of reliability, ICCs were strongest for monobenzyl phthalate (0.64) and weakest for the metabolites of di(2-ethylhexyl)phthalate (DEHP) (ranging from 0.13 to 0.22). Similarly, surrogate category analysis suggested that a single urine sample characterized an average 1-month exposure with reasonable accuracy across low, medium and high tertiles for all metabolites, except the DEHP metabolites. Geometric mean concentrations of monoethyl phthalate increased with age, but patterns by education, income, body mass index, environmental tobacco smoke or season were not observed when measures were adjusted for urinary dilution. Our results suggest that the participant characteristics assessed in this study have limited influence on inter-individual variability of phthalate metabolite concentrations. With regard to intra-individual variability, our results suggest that urinary concentrations of some phthalate metabolites are more reproducible over time and are less subjected to exposure misclassification than others (e.g., metabolites of DEHP).
Introduction
The diesters of 1,2-benzenedicarboxylic acid, referred to as phthalates, are industrial chemicals used widely in commercial, medical and personal care products to impart flexibility in plastics, retain color and fragrance in perfumes and cosmetics, add a gloss to lacquers or to provide time release for pharmaceuticals. High molecular weight phthalates, such as di(2-ethylhexyl)phthalate (DEHP) are used commonly as plasticizers in vinyl flooring and medical devices, whereas low molecular weight phthalates, such as diethyl phthalate and dibutyl phthalate (DBP) are used as solvents in toiletries and lacquers (ATSDR, 1995 (ATSDR, , 2001 (ATSDR, , 2003 . The ubiquitous use of phthalates results in human exposure through food sources, dermal absorption, inhalation and parenteral use of medical devices .
Exposure to phthalates among the general US population is widespread . The high potential for the developing fetus to be exposed has raised concerns regarding human health, given the reproductive and developmental toxicity shown in laboratory animals (Davis et al., 1994; Mylchreest et al., 1998 Mylchreest et al., , 1999 Mylchreest et al., , 2000 Gray et al., 2000 Gray et al., , 2006 . The epidemiologic investigation of potential phthalaterelated health effects involves the use of biomarkers for quantifying individual-level exposures from multiple sources. As non-persistent chemicals with short half-lives, urinary measurements of phthalate metabolites characterize recent exposures. It is unclear to what extent metabolite concentrations, detected in a single sample, may reliably characterize exposure patterns over longer time intervals. A limited number of studies have evaluated the temporal variability of phthalate metabolites in serial urine samples collected over time (Hoppin et al., 2002; Hauser et al., 2004; Fromme et al., 2007; Adibi et al., 2008; Teitelbaum et al., 2008) , but additional investigation is needed to elucidate patterns of within-and between-person variability in diverse populations. Given the paucity of exposure assessment studies in women of reproductive age, we conducted a study in a unique understudied population of Hmong females. The Hmong came to the United States as refugees from Laos after the Vietnam War, settling primarily in Wisconsin, Minnesota and California. As they have an unusually high birth rate when compared with other segments of the US population, they are particularly at risk from chemical exposures that affect reproductive health or fetal development. The goals of this study were (1) to evaluate the variability in urinary phthalate metabolites across three samples collected over B1 month from Hmong women of reproductive age; and (2) to assess the characteristics associated with phthalate exposures.
Methods

Study population
Forty-five Hmong women and their 20 spouses from Green Bay, Wisconsin, who were enrolled in the Fox River Environment and Diet Study (FRIENDS) between September 1999 and November 2005, were recruited to participate in a sub-study for evaluating phthalate exposures. The primary focus of FRIENDS was to evaluate the impact of polychlorinated biphenyl and methyl mercury exposures on reproductive health, as well as neuropsychological and auditory functions in children and adults. Informed consent was obtained from all subjects in this study, which was reviewed and approved by the Institutional Review Boards at the University of Illinois at Urbana/Champaign, Texas A&M Health Science Center, Michigan State University and the University of Oklahoma Health Sciences Center. The involvement of the Centers for Disease Control and Prevention (CDC) laboratory was limited and was determined not to constitute engagement in human subjects' research.
The eligibility criteria and recruitment methods for FRIENDS have been described earlier (Kornosky et al., 2008) . In brief, relationships with local Hmong associations were developed to assist in gaining the trust and cooperation required for a successful recruitment in this minority population. Given that Hmong have a limited number of clan names that were adopted as surnames, and assurances that virtually all Hmong households have telephones, Hmong households in the Green Bay area were identified by surnames in a continuously updated telephone directory (Metronet) and were contacted to participate by telephone. When contact could not be made by phone, interviewers visited their homes to conduct eligibility screening. Eligibility was restricted to married couples in which the woman was between the ages of 18 and 46 at the time of FRIENDS enrollment and the husband was at least 18 years of age. Because Hmong women have been reported to continue childbearing at later ages (Helsel et al., 1992) , the baseline enrollment criterion for women was extended beyond the traditional upper limit of age 40 commonly used in studies of reproductive outcomes. Through November 2005, a total of 175 enrolled couples completed baseline questionnaires, which collected information on demographic and lifestyle factors, fish-consumption patterns, exposure histories and reproductive history at the time of enrollment.
Sub-study
This sub-study had two primary goals. The first objective was to describe the distribution of urinary concentrations of phthalate metabolites among Hmong couples of reproductive age, and to explore the variability of the phthalate metabolite concentrations within households. The second objective was to evaluate the intra-and inter-individual variability in urinary metabolite concentrations. Recruitment occurred between May and November 2005, and all participants were asked to provide a first-morning urine sample and to complete an exposure assessment questionnaire. For the first objective, we recruited 20 women and their spouses and a single first-morning urine sample was collected from each participant. For the second objective, an additional 25 women were requested to provide three serial first-morning urine samples approximately every 2 weeks over a 1-month time period. The median interval between the first and second sample was 15 days, and 29.5 days between the first and third sample. As our focus in this report is on reproductive health among women, we restricted our analyses to females only, with the exception of the assessment of variability within households, which evaluated agreement between samples collected from 20 women and their husbands. Thus, this study population includes 45 women providing one to three urine samples (totaling 92 samples) and 20 men providing one sample each. A total of 71 FRIENDS female participants were approached for participation, resulting in a response rate of 63.4%. The primary reason provided for not participating was lack of time and interest. When the baseline characteristics of the substudy participants were compared with that of the remaining FRIENDS cohort, no differences were observed by age, body mass index (BMI) or education.
Data collection
Participants were provided with a urine collection kit containing instructions for the collection of a first-morning void and a polypropylene plastic urine collection cup that had been prescreened for phthalate metabolites. Participants were instructed to record the time of collection, place the sample immediately in the freezer and call the research staff on the day of collection to arrange for sample pickup. When the research staff member visited the home to retrieve the urine specimen, an exposure assessment questionnaire was administered. Owing to participant availability, the home visits occurred between 0 and 17 days (mean ¼ 1.2 days, SD ¼ 3.1 days) after urine sample collection. The questionnaire obtained information on age, weight, height, fish consumption, home furnishings and use of products that may contain phthalates. Additional demographic and health behavior data, such as education, household income and smoking status were available from baseline questionnaires administered at the time of enrollment into FRIENDS.
Measurement of phthalate metabolites
Urine samples were retrieved from the participants' home freezers and were stored frozen in the field office until shipped on dry ice to the CDC Division of Laboratory Sciences for processing and analysis. Phthalate metabolites were measured in urine to avoid potential contamination from the ubiquitous parent diesters, and because the metabolites are considered to be bioactive compounds . The analytical method for measuring the following 10 phthalate monoesters in urine has been described in detail (Kato et al., 2005) : monomethyl phthalate (MMP), monoethyl phthalate (MEP), monobenzyl phthalate (MBzP), mono-n-butyl phthalate (MnBP), mono-isobutyl phthalate (MiBP), mono(2-ethylhexyl) phthalate (MEHP), mono (2-ethyl-5-oxohexyl) phthalate (MEOHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-carboxypentyl) phthalate (MECPP) and mono(3-carboxypropyl) phthalate (MCPP). In brief, the analytical methodology involved enzymatic deconjugation of the phthalate metabolites from their glucuronidated form, followed by an online solid-phase extraction, separation with high performance liquid chromatography and detection by isotope-dilution tandem mass spectrometry. Quality control and reagent blank samples were included in each analytical batch along with the study samples. Limits of detection were: MMP, 1.0 mg/l; MEP, 0.4 mg/l; MBzP, 0.11 mg/l; MnBP, 0.4 mg/l; MiBP, 0.26 mg/l; MEHP, 0.9 mg/l; MEOHP, 0.45 mg/l; MEHHP, 0.32 mg/l; MECPP, 0.25 mg/l; and MCPP, 0.16 mg/l. The CDC analysts were blind to participant characteristics.
Statistical analysis
Statistical analyses were carried out using the SAS (Statistical Analysis System), version 9.1 (SAS Institute, Cary, NC, USA). Phthalate metabolite concentrations below the limits of detection were imputed by dividing the LOD by the square root of two (Hornung and Reed, 1990) . MMP, detected in only 17 of the 92 samples (18.5%), was not further evaluated in the analyses. The metabolites of DEHP (MEHP, MEOHP, MEHHP and MECPP) were evaluated individually and as the sum of the four (SDEHP). We calculated the descriptive statistics including geometric means and percentiles for the nine metabolites, which were detected in 480% of samples, and for SDEHP. The distribution of urinary concentrations of phthalate metabolites are reported in mg/l, as well as in mg/g creatinine to adjust the measurement for urine dilution (Jackson, 1966) . As some women provided up to three samples, the descriptive statistics are based on the mean concentrations for the 45 women.
Measurement variability was assessed using intraclass correlations (ICCs) and surrogate category analysis. The ICCs were calculated using random effects models, which were applied to the natural log-transformed data for estimating the within-subject and between-subject variance for each phthalate metabolite (Rosner, 2000) . The ICC is computed by dividing the estimate of the between-subject variance by the estimated total variance. As an indication of common household sources of phthalate exposures, we also calculated the ICCs to assess the correlation between the phthalate metabolite concentrations of 20 women and their spouses. Surrogate category analyses were limited to the 22 women who had provided a set of three samples. This analysis was conducted by first defining tertiles (low, medium, high) based on the distribution of the logtransformed concentrations of a single sample (referred to as the surrogate category). For each subject, the phthalate metabolite concentrations (log-transformed) were averaged across all three samples to represent the ''actual'' exposure over a 1-month time period. The mean of the average concentrations was then calculated separately for each tertile and back-transformed to display the geometric mean. A monotonic increase in geometric means across tertiles shows that categorical rankings from a single sample are representative of an average exposure over the 1-month period (Hauser et al., 2004) . The analyses were repeated using each of the three samples as the surrogate category.
To account for the lack of independence across samples collected from the same woman, we used linear mixed models to evaluate the association between participant characteristics and log-transformed phthalate metabolite concentrations. Associations were estimated by entering each characteristic into the model one at a time. Characteristics evaluated in this analysis included age at the time of specimen collection (19-29, 30-39, Z40 years), BMI (r25, 425-30, 430 kg/ m 2 ), education (no formal education, less than high school, high school graduate, more than high school), income (r$24,999, $25,000-39,999, $40,000-59,999) , ever smoked (yes/no), smoker at home (yes/no) and season of urine collection (May-August, September-November). Owing to very small numbers reporting fish consumption within the 48 h preceding urine collection (n ¼ 3), we did not investigate this factor further. We carried out tests for trend by entering ordinal variables into the linear mixed model for evaluating incremental changes in phthalate metabolite concentrations across consecutive categories of age, BMI, education and income.
Creatinine levels were examined to identify urine samples considered extremely dilute (o50 mg creatinine/dl) or concentrated (4300 mg creatinine/dl) (Alessio et al., 1985) . Separate analyses were conducted after excluding 16 samples (among 11 women) with creatinine levels outside the specified range. As the patterns of association were generally consistent, we report the results of analyses for all 92 urine samples contributed by 45 women, except where the assessment of variability was restricted to the 22 women providing three samples or to the 20 women whose spouses also provided specimens, as noted. All results are reported for creatinine-adjusted (mg/g creatinine) phthalate concentrations. The Supplementary Tables displaying results for unadjusted phthalate concentrations are available at the Journal of Exposure Science and Environmental Epidemiology website.
Results
Characteristics of the study population are presented in Table 1 . At the time of this sub-study in 2005, participants ranged in age from 19 to 51 years (mean 34.8 years, SD 8.4) and 60% (n ¼ 27) were overweight or obese, according to the BMI cut points of 425 or 430 kg/m 2 , respectively. Their spouses were similar in age (mean 35.3 years, SD 7.6, range 24-51) and mostly overweight (70%). A total of 60% of this Hmong female population reported less than a high school education, with nearly 40% reporting no formal education.
Of those with a formal education, the average education level was less than high school (mean years of education 11.4 years, SD 4.5). Correspondingly, household income did not exceed $25,000 for most women (56%). Smoking is uncommon among Hmong women. Only one participant reported ever smoking more than 100 cigarettes in her lifetime, and she was no longer a current smoker. However, B16% (n ¼ 7) lived with someone who smoked in the home.
Urine samples were collected between May and November of 2005, with 66% (n ¼ 61) obtained during the fall months (September through November). Twenty women provided a single urine sample, three women provided two samples and 22 women provided three samples. Seven of the 10 phthalate metabolites were detected in all 92 samples (Table 2 ). These included four hydrolytic monoesters (MEP, MnBP, MiBP and MBzP) and three oxidative metabolites of DEHP (MECPP, MEHHP and MEOHP). MEHP and MCPP were detected in 81% and 93% of samples, respectively. Selected percentiles of the distribution of creatinine-adjusted and unadjusted phthalate metabolites concentrations are reported in Table 2 . We observed a large degree of variability in phthalate metabolite concentrations across all samples. The geometric mean concentrations were highest for MEP, followed by MECPP, MnBP, MEHHP and MBzP. The rank order of geometric mean concentrations was identical for creatinine-adjusted and unadjusted values. The Supplementary information on the correlations between metabolites is available at the Journal of Exposure Science and Environmental Epidemiology website.
The ICCs for the phthalate metabolites are presented in Table 3 . As measures of reliability, the ICCs for samples collected over time were strongest for MBzP, MEP, MCPP, MnBP and MiBP and weakest for the metabolites of DEHP. The Spearman correlations between samples showed the same trend (data not shown). Although the rank order of ICCs differed for creatinine-adjusted and unadjusted concentrations, the metabolites with the top five ICCs remained the same. For these metabolites, the ICCs for the creatinineadjusted concentrations were consistently stronger (0.51-0.64) than for the unadjusted values (0.38-0.51). It must be noted that, when analyses were restricted to samples with creatinine concentrations between 50 and 300 mg creatinine/ dl, the magnitude of the ICCs increased substantially for the creatinine-adjusted and unadjusted measures of MBzP (0.84 and 0.72) and MCPP (0.73 and 0.69). Exclusion of dilute (n ¼ 14) and concentrated (n ¼ 2) samples had little effect on the ICCs computed for the remaining phthalate metabolites (data not shown). Correlations between spouses creatinineadjusted phthalate concentrations were strongest for MnBP, followed by MCPP, MBzP and MEP (Table 3) .
The results of the surrogate category analyses for the 22 women who provided three urine samples are displayed in Figure 1 . For five phthalate metabolites (MEP, MnBP, MiBP, MBzP and MCPP), the results show that using one urine specimen, whether the first, second or third sample collected over the 1-month time period, characterized an average 1-month exposure with reasonable accuracy across low, medium and high tertiles. In other words, when subjects were categorized into exposure tertiles using a single sample, the actual geometric mean concentrations of all three available samples were lowest for subjects placed in the bottom tertile, highest for subjects placed in the highest tertile and somewhere in between for subjects assigned to the middle tertile. Each of the four metabolites of DEHP and their sum (SDEHP) had one to two surrogate samples with nonmonotonic increases in geometric means, although in each case, the geometric mean for the highest tertile was more than two-fold greater than the geometric mean for the lowest tertile.
After the assessment of temporal variability within individuals, we went on to explore patterns of geometric mean phthalate concentrations by participant characteristics, passive tobacco smoke exposure in the home and season of specimen collection (Table 4) . Geometric mean concentrations of the creatinine-adjusted MEP increased with age (P for trend ¼ 0.03). No other phthalate concentrations were associated with age when adjusted for urinary dilution. Clear patterns by education and season were not apparent for creatinine-adjusted concentrations, but non-statistically significant patterns were observed for BMI, environmental tobacco smoke and income. With the exception of MEP and MiBP, concentrations of all metabolites were lowest among the obese group; but these differences were statistically significant only when evaluating concentrations unadjusted for urinary dilution. As only nine women were classified as obese, comparisons combining the overweight and obese categories were also conducted, but no differences in phthalate concentrations were detected. When compared with women in the highest income group ($40,000-59,999), creatinine-adjusted concentrations of MECPP, MEHHP, MEOHP and SDEHP were marginally higher among women in the middle income category ($25,000-39,999). The creatinine-adjusted concentrations of all metabolites were also somewhat lower among women reporting a smoker in the home, but marginally statistically significant differences were only detected for MEOHP and SDEHP. 
Discussion
Phthalate exposure is of potential concern for women of reproductive age because the developing fetus may be susceptible to endocrine-modulating effects. However, phthalate exposures in women of childbearing age are not well characterized, particularly among underserved populations and in specific ethnic groups that cannot be captured in nationally representative surveys, such as the National Health and Nutrition Examination Survey (NHANES). In our study, we investigated the temporal variability of phthalate exposures in a socioeconomically disadvantaged minority population of Southeast Asian women living in the area of Green Bay, Wisconsin, who emigrated to the United States from Laos and Thailand in the 1970s and thereafter. We found detectable urinary concentrations of 9 of the 10 phthalate metabolites measured in more than 80% of the samples analyzed with the highest concentrations observed for MEP. Five earlier studies have evaluated the temporal variability of phthalate metabolites in various populations over time periods ranging from days to months (Hoppin et al., 2002; Hauser et al., 2004; Fromme et al., 2007; Adibi et al., 2008; Teitelbaum et al., 2008) . Hoppin et al. (2002) assessed the agreement of phthalate measurements using first-morning urine samples collected on two consecutive days from 46 African-American women. Hauser et al. (2004) reported the temporal variability of phthalate concentrations among 11 men who each provided 9 samples over a 3-month period. Each of these earlier studies assessed MEP, MBP, MBzP and MEHP, but did not measure the oxidative metabolites of DEHP. More recently, Fromme et al. (2007) determined phthalate metabolites in the morning urine of 50 German men and women aged 14-60 across 8 consecutive days. Teitelbaum et al. (2008) collected two to seven urine samples over 6 months in 35 Hispanic and Black children aged 6-10 years old. Adibi et al. (2008) described phthalate measurements in 28 pregnant Dominican and African-American women, who gave two to four urine samples over a 6-week period during the third trimester. In accordance with the ICCs reported previously for creatinine-adjusted MEHP, MEHHP, MEOHP and MECPP over 8 days to 6 months (Fromme et al., 2007; Adibi et al., 2008; Teitelbaum et al., 2008) , our evaluation of measurement agreement over a 1-month period found these metabolites to have poor reliability (ICCo0.22). We found MBzP to be the most reproducible metabolite. Furthermore, the magnitude of the ICC for MBzP has been relatively consistent across earlier studies (range 0.53-0.64) suggesting that exposures to BBzP may be fairly consistent over time and within particular age and racial-ethnic groups. As BBzP is used commonly in home furnishings, such as vinyl floor tiles, vinyl wallpaper and carpet backing, it would seem reasonable that leaching or evaporation into indoor air would be a relatively consistent source of exposure through inhalation and ingestion for individuals living or working around such materials. Compared with MBzP, the reproducibility of measurements for MEP, MnBP and MiBP is less consistent across earlier studies, but patterns of the decreasing ICCs with increasing sampling intervals are not observed across studies. Our results show moderately strong reproducibility for these biomarkers over a 1-month sampling interval. Furthermore, the strong magnitude of the MnBP, MCPP, MBzP and MEP correlations between spouses suggests that the primary sources of such exposures may originate from the shared home environment and common lifestyle habits.
In agreement with the surrogate category analyses reported by Hauser et al. (2004) and Teitelbaum et al. (2008) , a single urine sample was found to provide a reasonable prediction of high, medium and low categories of exposures to MEP, MBzP, MnBP and MiBP, as well as MCPP, which was assessed only by Teitelbaum. Unlike Teitelbaum, our results did not provide a good support for the use of a single sample to indicate accurate exposure categories for DEHP metabolites. This may reflect differences in the timing of urine collection (firstmorning versus convenience sampling) or differences in phthalate exposure patterns among children compared to women of reproductive age. Although Hauser et al. (2004) did not measure the oxidative metabolites of DEHP, MEHP was reported as the least-predictive metabolite of those evaluated. The MEHP monoester of DEHP is further metabolized by oxidation to several oxidative metabolites including MEOHP, MEHHP and MECPP. Thus, the more complex metabolism of higher molecular weight phthalates, such as DEHP could lead to greater within-subject variability.
Although caution needs to be exercised when making comparisons across studies that employ different study designs or target different populations, our study confirms earlier reports of detectable concentrations of urinary phthalate metabolites for the general US population Centers for Disease Control and Prevention, 2005 ) and other female populations, which included pregnant women (Adibi et al., 2003 (Adibi et al., , 2008 Swan et al., 2005; Wolff et al., 2008; Ye et al., 2008) , middle-aged African-American women (Hoppin et al., 2002) , young girls (Wolff et al., 2007) and German females (Koch et al., 2003) (Table 5) . Consistent with these findings, MEP was the phthalate metabolite detected in urine at the highest median concentrations, although in our study, median MEP concentrations (60.6 mg/g creatinine) were markedly lower than that of background levels in the United States, averaging one-third of the concentrations reported for females (age Z6 years) in NHANES 2001-2002 (171 mg/g creatinine) (Centers for Disease Control and Prevention, 2005) . Increased MEP concentrations have been previously linked with smoking and use of personal care products, such as perfumes (Duty et al., 2005) . Although Hmong women have a lower prevalence of smoking when compared with that of other ethnic groups, the degree to which lower MEP exposures in this population may be attributed to less-frequent use of fragranced or other personal care products was not evaluated, as identifying sources of phthalate exposure was beyond the scope of this paper. Although MEP concentrations increased markedly with age in a clear dose-response fashion, we did not observe similar trends for any of the other phthalate metabolites. Although age patterns are not evaluated directly in the NHANES data, our data are consistent with the suggestion of an age trend, as shown by increasing MEP concentrations across children, adolescent and adult categories (Centers for Disease Control and Prevention, 2005) .
In contrast to our observations for MEP, median concentrations of MiBP and MBzP were B2.7-fold (7.3 compared with 2.7 mg/g creatinine) and 1.6-fold (24.1 compared with 15.1 mg/g creatinine) greater in our study population compared with that in the general US population. All other phthalate metabolites were present in our study population at concentrations similar to or slightly lower than Consistent with earlier reports Koch et al., 2003) , the oxidative metabolites of DEHP exceeded the urinary concentrations of MEHP by four-to ten-fold. All DEHP metabolites were correlated strongly (rZ0.92) Koch et al., 2003; Silva et al., 2006) as expected, since they derive from a common parent compound. Similarly, the positive correlation that we observed between MnBP and MBzP concentrations (r ¼ 0.54) is consistent with the evidence that these metabolites arise from a common diester, BBzP. BBzP predominantly metabolizes to MBzP, with lesser quantities eliminated as MnBP (Anderson et al., 2001) . However, DBP is the primary source of MnBP excretion (Anderson et al., 2001) ; thus, exposure to common sources of BBzP and DBP may contribute to the observed correlation. Similarly, the strong positive correlation between MnBP and its structural isomer MiBP (r ¼ 0.54) may be attributed to the use of DBP and di-isobutyl phthalate in similar commercial applications, such as in paints, printing inks, adhesives, insecticides, nail polish and cosmetics. Although the magnitude of the associations are somewhat attenuated, MnBP (r ¼ 0.44) and MiBP (r ¼ 0.44) are also positively correlated with MCPP concentrations, which reflects the metabolic breakdown of DBP into MnBP and small quantities of MCPP (Centers for Disease Control and Prevention, 2005; Silva et al., 2007) .
Data regarding sociodemographic characteristics associated with urinary phthalate metabolite concentrations are scarce. Using data collected as part of the NHANES III examination of urinary phthalate monoester concentrations (Blount et al., 2000) , Koo et al. (Koo et al., 2002) examined the association between various sociodemograhic characteristics and phthalate exposures. Lower household income levels, defined as o$1500 during the month before sampling, were associated with increased estimates of exposure to DEHP and BBzP. In our sample, in which over half of the women (n ¼ 25) reported household incomes of o$25,000 annually, there was no clear pattern between income and creatinine-adjusted phthalate metabolite concentrations, with the exception of marginally significant increases in the concentrations of DEHP oxidative metabolites, MECPP, MEHHP and MEOHP in the middle income group. Only a few studies have reported on the association between various phthalate monoesters and anthropometric measures, and two were restricted to male subjects (Duty et al., 2005; Stahlhut et al., 2007; Hatch et al., 2008) . One study examining the relationship between usage of various personal products and phthalate exposures among men reported a weak correlation between BMI and MEP concentrations (Spearman correlation coefficient ¼ 0.1, Po0.05) (Duty et al., 2005) . A recent study also found statistically significant positive correlations between the urinary concentrations of four phthalate metabolites, MBzP, MEHHP, MEOHP and MEP, and increased abdominal adiposity in the male NHANES participants (Stahlhut et al., 2007) . In a separate analysis of the NHANES data, Hatch et al. (2008) reported increasing BMI and waist circumference with increasing MEP quartiles in adolescent girls, with a similar but somewhat weaker association observed in women between the ages of 20 and 59. In our sample of women with 60% (n ¼ 27) classified as overweight or obese, we observed an association between BMI and MEP (Spearman correlation ¼ 0.26, P ¼ 0.08), utilizing the mean MEP concentrations for each woman. Correlations between BMI and other phthalate metabolites were not observed. There was a pattern of slightly higher geometric mean concentrations (creatinine-adjusted) for most of the metabolites, most notably for MEP, among overweight versus normal weight women. However, the results may be the outcome of overweight women having less muscle mass and, therefore, lower creatinine levels. This pattern was not sustained among women classified as obese; although, this may be because of the very small numbers in this category (n ¼ 9). Future investigations evaluating larger sample sizes are needed to further explore the relationship between BMI and phthalate metabolites.
This study has several important strengths. Our study population is a distinct minority population in the United States, which is characterized by a unique set of cultural factors including an unusually high birth rate that make this group an important population in which to investigate the effects of environmental exposures that may impair reproductive health or fetal development. To our knowledge, this is the first study to evaluate phthalate exposure among the Hmong population. We minimized a potential source of inter-individual variability in concentrations of phthalate metabolites by restricting the window of urine sample collection to that of first-morning voids. We also collected repeated measurements on over one-half of our study participants; thus, we could examine temporal variability and the effect of exposure determinants on urinary phthalate metabolites while incorporating intra-individual variability in phthalate concentrations in the analyses that were conducted. Finally, a greater number of urinary phthalate metabolites were evaluated in our investigation as compared with that in several earlier studies (see Table 5 ), which provided an opportunity to better characterize phthalate exposure in this understudied population.
Although it is informative to compare the distribution of phthalate metabolites concentrations observed in this minority population with reference levels for females in the general US population, these comparisons should be interpreted with caution due to the small sample size, differences in the timing of urine collection and the restricted age distribution of our sample. Differences in phthalate metabolite concentrations between Hmong women and the general population could be attributed to differences in exposure patterns, geographic or diurnal variations, population characteristics or pharmacokinetic factors influenced by age or race-ethnicity. The Hmong population was largely comprised non-smokers with limited educational attainment and low household income. The lack of variability by smoking status and recent fish consumption restricted our ability to assess these factors. Furthermore, insufficient proportions of individuals with more than a high school education or household income of $40,000 or above limited our assessment of phthalate exposure patterns across all levels of education and income. Finally, assessment of environmental tobacco smoke exposure was self-reported and limited to exposure at home.
The findings of this study support the evidence that environmental phthalate exposures are also prevalent among women of reproductive age in underserved populations. Phthalate metabolites concentrations are reproducible over a 1-month sampling interval for most measured metabolites, but caution must be exercised when using single samples to estimate exposure to DEHP. Sociodemographic and lifestyle factors that increase the likelihood of exposure have not been well delineated and should be further explored. Given the limited number of studies in reproductive-aged women, future investigations are required for determining whether adverse reproductive outcomes are associated with phthalate exposures at levels that have been commonly observed in the population.
